Synthesis and biological evaluation of andrographolide analogues as anti-cancer agents. 2014

Ranjan Preet, and Biswajit Chakraborty, and Sumit Siddharth, and Purusottam Mohapatra, and Dipon Das, and Shakti Ranjan Satapathy, and Supriya Das, and Nakul C Maiti, and Prakas R Maulik, and Chanakya Nath Kundu, and Chinmay Chowdhury
Cancer Biology Division, KIIT School of Biotechnology, KIIT University, Campus-11, Patia, Bhubaneswar, Odisha 751024, India.

A new family of andrographolide analogues were synthesized and screened in vitro against kidney (HEK-293) and breast (MCF-7) cancer cells. The anti-cancer effects of the active analogues (2b, 2c and 4c) were determined by multiple cell based assays such as MTT, immunostaining, FACS, western blotting and transcriptional inhibition of NF-κB activity. Importantly, these compounds were found to possess higher anti-cancer potency than andrographolide and low toxicity to normal (VERO and MCF-10A) cells. Increased level of Bax/Bcl-xL ratio, caspase 3, and sub G1 population, higher expression level of tumor suppressor protein p53 and lower expression level of NF-κB suggested potent apoptotic property of the active analogues. Data revealed that the andrographolide derivative-mediated cell death in cancer cells was p53 dependent.

UI MeSH Term Description Entries
D004224 Diterpenes Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate. Diterpene,Diterpenes, Cembrane,Diterpenes, Labdane,Diterpenoid,Labdane Diterpene,Norditerpene,Norditerpenes,Norditerpenoid,Cembranes,Diterpenoids,Labdanes,Norditerpenoids,Cembrane Diterpenes,Diterpene, Labdane,Labdane Diterpenes
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Ranjan Preet, and Biswajit Chakraborty, and Sumit Siddharth, and Purusottam Mohapatra, and Dipon Das, and Shakti Ranjan Satapathy, and Supriya Das, and Nakul C Maiti, and Prakas R Maulik, and Chanakya Nath Kundu, and Chinmay Chowdhury
August 2012, Archiv der Pharmazie,
Ranjan Preet, and Biswajit Chakraborty, and Sumit Siddharth, and Purusottam Mohapatra, and Dipon Das, and Shakti Ranjan Satapathy, and Supriya Das, and Nakul C Maiti, and Prakas R Maulik, and Chanakya Nath Kundu, and Chinmay Chowdhury
December 2013, Bioorganic & medicinal chemistry,
Ranjan Preet, and Biswajit Chakraborty, and Sumit Siddharth, and Purusottam Mohapatra, and Dipon Das, and Shakti Ranjan Satapathy, and Supriya Das, and Nakul C Maiti, and Prakas R Maulik, and Chanakya Nath Kundu, and Chinmay Chowdhury
June 2013, Bioorganic & medicinal chemistry letters,
Ranjan Preet, and Biswajit Chakraborty, and Sumit Siddharth, and Purusottam Mohapatra, and Dipon Das, and Shakti Ranjan Satapathy, and Supriya Das, and Nakul C Maiti, and Prakas R Maulik, and Chanakya Nath Kundu, and Chinmay Chowdhury
December 2012, Bioorganic & medicinal chemistry letters,
Ranjan Preet, and Biswajit Chakraborty, and Sumit Siddharth, and Purusottam Mohapatra, and Dipon Das, and Shakti Ranjan Satapathy, and Supriya Das, and Nakul C Maiti, and Prakas R Maulik, and Chanakya Nath Kundu, and Chinmay Chowdhury
January 2015, Anti-cancer agents in medicinal chemistry,
Ranjan Preet, and Biswajit Chakraborty, and Sumit Siddharth, and Purusottam Mohapatra, and Dipon Das, and Shakti Ranjan Satapathy, and Supriya Das, and Nakul C Maiti, and Prakas R Maulik, and Chanakya Nath Kundu, and Chinmay Chowdhury
August 2022, ChemistrySelect,
Ranjan Preet, and Biswajit Chakraborty, and Sumit Siddharth, and Purusottam Mohapatra, and Dipon Das, and Shakti Ranjan Satapathy, and Supriya Das, and Nakul C Maiti, and Prakas R Maulik, and Chanakya Nath Kundu, and Chinmay Chowdhury
September 2006, Journal of medicinal chemistry,
Ranjan Preet, and Biswajit Chakraborty, and Sumit Siddharth, and Purusottam Mohapatra, and Dipon Das, and Shakti Ranjan Satapathy, and Supriya Das, and Nakul C Maiti, and Prakas R Maulik, and Chanakya Nath Kundu, and Chinmay Chowdhury
January 2018, Current pharmaceutical design,
Ranjan Preet, and Biswajit Chakraborty, and Sumit Siddharth, and Purusottam Mohapatra, and Dipon Das, and Shakti Ranjan Satapathy, and Supriya Das, and Nakul C Maiti, and Prakas R Maulik, and Chanakya Nath Kundu, and Chinmay Chowdhury
July 2019, Bioorganic & medicinal chemistry,
Ranjan Preet, and Biswajit Chakraborty, and Sumit Siddharth, and Purusottam Mohapatra, and Dipon Das, and Shakti Ranjan Satapathy, and Supriya Das, and Nakul C Maiti, and Prakas R Maulik, and Chanakya Nath Kundu, and Chinmay Chowdhury
March 2014, Chemical biology & drug design,
Copied contents to your clipboard!